Toll-like receptor 4, as one of the most researched TLRs, was significantly activated after cerebral ischemia, and the inhibition of TLR4 could effectively reduce inflammation following ischemic stroke (Andresen et al., 2016). Here, TLR4 is linked to brain ischemia.